FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Eva Lengfelder

Research Profile

Disorders

Phenomena

Radioactive Hazard Release

Chemicals & Drugs

Procedures

Co-author Network

Publications

TOP 3
Florian Nolte; Daniel Nowak; Verena Nowak; Mark Reinwald; Cristina Sauerland; Karsten Spiekermann; Thomas Büchner; Andreas Faldum; Benjamin Hanfstein; Anna Hecht; Wolf-Karsten Hofmann; Eva Lengfelder
In acute promyelocytic leukemia (APL) low BAALC gene expression identifies a patient group with favorable overall survival and improved relapse free survival.
Anna Hecht; Wolf-Karsten Hofmann; Eva Lengfelder; Daniel Nowak; Verena Nowak; Cristina Sauerland; Karsten Spiekermann; Thomas Büchner; Andreas Faldum; Benjamin Hanfstein; Florian Nolte
High expression of the Ets-related gene (ERG) is an independent prognostic marker for relapse-free survival in patients with acute promyelocytic leukemia.
Till Schoofs; Isabell Schulze; Monika Stoll; Anika Witten; Christian Rohde; Frank Rosenbauer; Peter Schlenke; Shuchi Agrawal-Singh; Wolfgang E Berdel; Thomas Büchner; Nikolaj Dietrich; Martin Dugas; Stefanie Göllner; Klaus Hansen; Katja Hebestreit; Wolf-Karsten Hofmann; Hans-Ulrich Klein; Eva Lengfelder; Mads Lerdrup; Carsten Müller-Tidow
DNA methylation changes are a late event in acute promyelocytic leukemia and coincide with loss of transcription factor binding.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Eva Lengfelder (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Florian Nolte; Daniel Nowak; Verena Nowak; Mark Reinwald; Cristina Sauerland; Karsten Spiekermann; Thomas Büchner; Andreas Faldum; Benjamin Hanfstein; Anna Hecht; Wolf-Karsten Hofmann; Eva Lengfelder
In acute promyelocytic leukemia (APL) low BAALC gene expression identifies a patient group with favorable overall survival and improved relapse free survival.
Leukemia research 2013;37(4):378-82.
2013: Anna Hecht; Wolf-Karsten Hofmann; Eva Lengfelder; Daniel Nowak; Verena Nowak; Cristina Sauerland; Karsten Spiekermann; Thomas Büchner; Andreas Faldum; Benjamin Hanfstein; Florian Nolte
High expression of the Ets-related gene (ERG) is an independent prognostic marker for relapse-free survival in patients with acute promyelocytic leukemia.
Annals of hematology 2013;92(4):443-9.
2013: Till Schoofs; Isabell Schulze; Monika Stoll; Anika Witten; Christian Rohde; Frank Rosenbauer; Peter Schlenke; Shuchi Agrawal-Singh; Wolfgang E Berdel; Thomas Büchner; Nikolaj Dietrich; Martin Dugas; Stefanie Göllner; Klaus Hansen; Katja Hebestreit; Wolf-Karsten Hofmann; Hans-Ulrich Klein; Eva Lengfelder; Mads Lerdrup; Carsten Müller-Tidow
DNA methylation changes are a late event in acute promyelocytic leukemia and coincide with loss of transcription factor binding.
Blood 2013;121(1):178-87.
2013: Eva Lengfelder; Carsten Müller-Tidow; Cristina Sauerland; Stephanie Schneider; Susanne Schnittger; Beate Schultheis; Hubert Serve; Karsten Spiekermann; Bernhard Wörmann; Carlo Aul; Wolfgang E Berdel; Jan Braess; Thomas Büchner; Philipp Erben; Claudia Haferlach; Torsten Haferlach; Benjamin Hanfstein; Rüdiger Hehlmann; Achim Heinecke; Wolfgang Hiddemann; Wolf-Karsten Hofmann; Heinz A Horst; Karl-Anton Kreuzer; Utz Krug
Outcome of elderly patients with acute promyelocytic leukemia: results of the German Acute Myeloid Leukemia Cooperative Group.
Annals of hematology 2013;92(1):41-52.
2012: Daniel Nowak; Verena Nowak; Julia Oblaender; Seishi Ogawa; Andreas Reiter; Susanne Saussele; Brigitte Schlegelberger; Wolfgang Seifarth; Christel Weiss; Jan Braess; Thomas Buechner; Philipp Erben; Alice Fabarius; Claudia Haferlach; Benjamin Hanfstein; Anna Hecht; Wolf-Karsten Hofmann; Gero Hütter; Marion Klaumuenzer; Alexander Kohlmann; Maximilian Mossner; Martin C Müller; Florian Nolte; Eva Lengfelder
SNP array analysis of acute promyelocytic leukemia may be of prognostic relevance and identifies a potential high risk group with recurrent deletions on chromosomal subband 1q31.3.
Genes, chromosomes & cancer 2012;51(8):756-67.
2012: Carsten Müller; Niels Murawski; Christina Nickenig; Norma Peter; Michael Pfreundschuh; Viola Poeschel; Tanja Rixecker; Michael Wenger; Martin H J Wiesen; Samira Zeynalova; Carsten Zwick; Gerhard Held; Eva Lengfelder; Bernd Metzner; Marcel Reiser
The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL.
Blood 2012;119(14):3276-84.
2012: Eva Lengfelder; Wolf-Karsten Hofmann; D Nowak
Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia.
Leukemia 2012;26(3):433-42.
2010: Christoph Walz; David Grimwade; Susanne Saussele; Eva Lengfelder; Claudia Haferlach; Susanne Schnittger; Marina Lafage-Pochitaloff; Andreas Hochhaus; Nicholas C P Cross; Andreas Reiter
Atypical mRNA fusions in PML-RARA positive, RARA-PML negative acute promyelocytic leukemia.
Genes, chromosomes & cancer 2010;49(5):471-9.
2009: Eva Lengfelder; Claudia Haferlach; Susanne Saussele; Torsten Haferlach; Beate Schultheis; S Schnittger; Wolf-Dieter Ludwig; Peter Staib; Carlo Aul; A Grüneisen; W Kern; A Reichle; Hubert Serve; Wolfgang E Berdel; J Braess; K Spiekermann; Bernhard Wörmann; Maria Cristina Sauerland; Achim Heinecke; Wolfgang Hiddemann; Rüdiger Hehlmann; Thomas Büchner
High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG.
Leukemia 2009;23(12):2248-58.
2009: Stephan Stilgenbauer; Thorsten Zenz; Dirk Winkler; Andreas Bühler; Richard F Schlenk; Silja Groner; Raymonde Busch; Manfred Hensel; Ulrich Dührsen; Jürgen Finke; Peter Dreger; Ulrich Jäger; Eva Lengfelder; Karin Hohloch; Ulrike Söling; Rudolf Schlag; Michael Kneba; Michael Hallek; Hartmut Döhner
Subcutaneous alemtuzumab in fludarabine-refractory chronic lymphocytic leukemia: clinical results and prognostic marker analyses from the CLL2H study of the German Chronic Lymphocytic Leukemia Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(24):3994-4001.
2009: Giovanni Barosi; Gunnar Birgegård; Guido Finazzi; Martin Griesshammer; Claire Harrison; Hans Carl Hasselbalch; Jean-Jacques Kiladjian; Eva Lengfelder; Mary Frances McMullin; Francesco Passamonti; John T Reilly; Alessandro M Vannucchi; Tiziano Barbui
Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference.
Blood 2009;113(20):4829-33.
2009: Thomas Büchner; Wolfgang E Berdel; Claudia Haferlach; Torsten Haferlach; Susanne Schnittger; Carsten Müller-Tidow; Jan Braess; Karsten Spiekermann; Joachim Kienast; Peter Staib; Andreas Grüneisen; Wolfgang Kern; Albrecht Reichle; Georg Maschmeyer; Carlo Aul; Eva Lengfelder; Maria Cristina Sauerland; Achim Heinecke; Bernhard Wörmann; Wolfgang Hiddemann
Age-related risk profile and chemotherapy dose response in acute myeloid leukemia: a study by the German Acute Myeloid Leukemia Cooperative Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(1):61-9.
2008: Michael Pfreundschuh; Joerg Schubert; Marita Ziepert; Rudolf Schmits; Martin Mohren; Eva Lengfelder; Marcel Reiser; Christina Nickenig; Michael Clemens; Norma Peter; Carsten Bokemeyer; Hartmut Eimermacher; Anthony Ho; Martin Hoffmann; Roland Mertelsmann; Lorenz Trümper; Leopold Balleisen; Ruediger Liersch; Bernd Metzner; Frank Hartmann; Bertram Glaß; Viola Poeschel; Norbert Schmitz; Christian Ruebe; Alfred C Feller; Markus Loeffler
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).
The lancet oncology 2008;9(2):105-16.
2007: Eva Lengfelder; Beate Schultheis; T Büchner; Rüdiger Hehlmann
[Arsenic trioxide: "a successful poison" in patients with acute promyelocytic leukemia].
Deutsche medizinische Wochenschrift (1946) 2007;132(7):330-6.
2007: Giovanni Barosi; C Besses; Gunnar Birgegård; Jean Briere; Francisco Cervantes; Guido Finazzi; Heinz Gisslinger; Martin Griesshammer; Luigi Gugliotta; C Harrison; Hans Carl Hasselbalch; Eva Lengfelder; John T Reilly; JJ Michiels; Tiziano Barbui
A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working group.
Leukemia 2007;21(2):277-80.
2006: Christoph Walz; Claire Curtis; Susanne Schnittger; Beate Schultheis; Georgia Metzgeroth; Claudia Schoch; Eva Lengfelder; Philipp Erben; Martin C Müller; Torsten Haferlach; Andreas Hochhaus; Rüdiger Hehlmann; Nicholas C P Cross; Andreas Reiter
Transient response to imatinib in a chronic eosinophilic leukemia associated with ins(9;4)(q33;q12q25) and a CDK5RAP2-PDGFRA fusion gene.
Genes, chromosomes & cancer 2006;45(10):950-6.
2006: Christina Nickenig; Martin Dreyling; Eva Hoster; Michael Pfreundschuh; Lorenz Trumper; Marcel Reiser; Hannes Wandt; Eva Lengfelder; Michael Unterhalt; Wolfgang Hiddemann
Combined cyclophosphamide, vincristine, doxorubicin, and prednisone (CHOP) improves response rates but not survival and has lower hematologic toxicity compared with combined mitoxantrone, chlorambucil, and prednisone (MCP) in follicular and mantle cell lymphomas: results of a prospective randomized trial of the German Low-Grade Lymphoma Study Group.
Cancer 2006;107(5):1014-22.
2006: Thomas Büchner; Wolfgang E Berdel; Claudia Schoch; Torsten Haferlach; Hubert Serve; Joachim Kienast; Susanne Schnittger; Wolfgang Kern; Joëlle Tchinda; Albrecht Reichle; Eva Lengfelder; Peter Staib; Wolf-Dieter Ludwig; Carlo Aul; Hartmut Eimermacher; Leopold Balleisen; Maria Cristina Sauerland; Achim Heinecke; Bernhard Wörmann; Wolfgang Hiddemann
Double induction containing either two courses or one course of high-dose cytarabine plus mitoxantrone and postremission therapy by either autologous stem-cell transplantation or by prolonged maintenance for acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(16):2480-9.
2006: Amy V Jones; Richard T Silver; Katherine Waghorn; Claire Curtis; Sebastian Kreil; Katerina Zoi; Andreas Hochhaus; David Oscier; Georgia Metzgeroth; Eva Lengfelder; Andreas Reiter; Andrew Chase; Nicholas C P Cross
Minimal molecular response in polycythemia vera patients treated with imatinib or interferon alpha.
Blood 2006;107(8):3339-41.
2006: Eva Lengfelder; Kirsten Merx; Rüdiger Hehlmann
Diagnosis and therapy of polycythemia vera.
Seminars in thrombosis and hemostasis 2006;32(3):267-75.
2006: Martin Sattler; Christoph Walz; Brian J Crowley; Eva Lengfelder; Pasi A Janne; Andrew M Rogers; Yanan Kuang; Robert Distel; Andreas Reiter; James D Griffin
A sensitive high-throughput method to detect activating mutations of Jak2 in peripheral-blood samples.
Blood 2006;107(3):1237-8.
2005: Wolfgang Hiddemann; Michael Kneba; Martin Dreyling; Norbert Schmitz; Eva Lengfelder; Rudolf Schmits; Marcel Reiser; Bernd Metzner; Harriet Harder; Susanna Hegewisch-Becker; Thomas Fischer; Martin Kropff; Hans-Edgar Reis; Mathias Freund; Bernhard Wörmann; Roland Fuchs; Manfred Planker; Jörg Schimke; Hartmut Eimermacher; Lorenz Trümper; Ali Aldaoud; Reza Parwaresch; Michael Unterhalt
Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group.
Blood 2005;106(12):3725-32.
2005: Thomas Büchner; Wolfgang E Berdel; Bernhard Wörmann; Claudia Schoch; Torsten Haferlach; Susanne Schnittger; Wolfgang Kern; Carlo Aul; Eva Lengfelder; Andrea Schumacher; Albrecht Reichle; Peter Staib; Leopold Balleisen; Hartmut Eimermacher; Andreas Grüneisen; Herbert Rasche; Maria Cristina Sauerland; Achim Heinecke; Rolf M Mesters; Hubert Serve; Joachim Kienast; Wolfgang Hiddemann
Treatment of older patients with AML.
Critical reviews in oncology/hematology 2005;56(2):247-59.
2005: Eva Lengfelder; Susanne Saussele; Andreas Weisser; Thomas Büchner; Rüdiger Hehlmann
Treatment concepts of acute promyelocytic leukemia.
Critical reviews in oncology/hematology 2005;56(2):261-74.
2005: Christian Langer; Eva Lengfelder; Jürgen Thiele; Hans Michael Kvasnicka; Heike L Pahl; Heimo Beneke; Stefanie Schauer; Heinz Gisslinger; Martin Griesshammer
Pegylated interferon for the treatment of high risk essential thrombocythemia: results of a phase II study.
Haematologica 2005;90(10):1333-8.
2005: Amy V Jones; Sebastian Kreil; Katerina Zoi; Katherine Waghorn; Claire Curtis; Lingyan Zhang; Joannah Score; Rachel Seear; Andrew Chase; Francis H Grand; Helen White; Christine Zoi; Dimitris Loukopoulos; Evangelos Terpos; Elisavet-Christine Vervessou; Beate Schultheis; Michael Emig; Thomas Ernst; Eva Lengfelder; Rüdiger Hehlmann; Andreas Hochhaus; David Oscier; Richard T Silver; Andreas Reiter; Nicholas C P Cross
Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders.
Blood 2005;106(6):2162-8.
2004: Ole Maywald; Dieter Buchheidt; Jörg Bergmann; Claudia Schoch; W-D Ludwig; Andreas Reiter; Jan Hastka; Eva Lengfelder; Rüdiger Hehlmann
Spontaneous remission in adult acute myeloid leukemia in association with systemic bacterial infection-case report and review of the literature.
Annals of hematology 2004;83(3):189-94.
2004: Andreas Reiter; Eva Lengfelder; David Grimwade
Pathogenesis, diagnosis and monitoring of residual disease in acute promyelocytic leukaemia.
Acta haematologica 2004;112(1-2):55-67.
2004: Thomas Büchner; Wolfgang Hiddemann; Wolfgang E Berdel; Bernhard Wörmann; Claudia Schoch; Christa Fonatsch; Helmut Löffler; Torsten Haferlach; Wolf-Dieter Ludwig; Georg Maschmeyer; Peter Staib; Leopold Balleisen; Andreas Grüneisen; Carlo Aul; Eva Lengfelder; Rüdiger Hehlmann; Wolfgang Kern; Hubert Serve; Rolf M Mesters; Hartmut Eimermacher; Norbert Frickhofen; Joachim Kienast; A Giagounidis; Maria Cristina Sauerland; Achim Heinecke
Subgroup specific therapy effects in AML: AMLCG data.
Annals of hematology 2004;83 Suppl 1():S100-1.
2004: Eva Lengfelder; Andreas Reiter; Susanne Saussele; Andreas Weisser; Rüdiger Hehlmann
Monitoring of minimal residual disease in acute promyelocytic leukemia.
Annals of hematology 2004;83 Suppl 1():S79-80.
2003: Thomas Büchner; Wolfgang Hiddemann; Wolfgang E Berdel; Bernhard Wörmann; Claudia Schoch; Christa Fonatsch; Helmut Löffler; Torsten Haferlach; Wolf-Dieter Ludwig; Georg Maschmeyer; Peter Staib; Carlo Aul; Andreas Gruneisen; Eva Lengfelder; Norbert Frickhofen; Wolfgang Kern; Hubert Serve; Rolf M Mesters; Maria Cristina Sauerland; Achim Heinecke
6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(24):4496-504.
2003: Eva Lengfelder; U Gnad; T Büchner; Rüdiger Hehlmann
Treatment of relapsed acute promyelocytic leukemia.
Onkologie 2003;26(4):373-9.
2003: Andreas Reiter; Susanne Saussele; David Grimwade; Joseph L Wiemels; Mark Segal; Marina Lafage-Pochitaloff; Christoph Walz; Andreas Weisser; Andreas Hochhaus; Andreas Willer; Anja Reichert; Thomas Büchner; Eva Lengfelder; Rüdiger Hehlmann; Nicholas C P Cross
Genomic anatomy of the specific reciprocal translocation t(15;17) in acute promyelocytic leukemia.
Genes, chromosomes & cancer 2003;36(2):175-88.
2003: Torsten Haferlach; Claudia Schoch; Helmut Löffler; Winfried Gassmann; Wolfgang Kern; Susanne Schnittger; Christa Fonatsch; Wolf-Dieter Ludwig; Christian Wuchter; Brigitte Schlegelberger; Peter Staib; Albrecht Reichle; Uschi Kubica; Hartmut Eimermacher; Leopold Balleisen; Andreas Grüneisen; Detlef Haase; Carlo Aul; Jochen Karow; Eva Lengfelder; Bernhard Wörmann; Achim Heinecke; Maria Cristina Sauerland; Thomas Büchner; Wolfgang Hiddemann
Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(2):256-65.
2002: Thomas Büchner; Wolfgang Hiddemann; Wolfgang E Berdel; Bernhard Wörmann; Claudia Schoch; Helmut Löffler; Torsten Haferlach; Andrea Schumacher; Peter Staib; Leopold Balleisen; Andreas Grüneisen; Herbert Rasche; Carlo Aul; Axel Heyll; Eva Lengfelder; Wolf-Dieter Ludwig; Georg Maschmeyer; Hartmut Eimermacher; Jochen Karow; Norbert Frickhofen; Wolf-Dietrich Hirschmann; Maria Cristina Sauerland
Acute myeloid leukemia: treatment over 60.
Reviews in clinical and experimental hematology 2002;6(1):46-59; discussion 86-7.
2002: Claudia Schoch; Susanne Schnittger; Wolfgang Kern; Eva Lengfelder; Helmut Löffler; Wolfgang Hiddemann; Torsten Haferlach
Rapid diagnostic approach to PML-RARalpha-positive acute promyelocytic leukemia.
The hematology journal : the official journal of the European Haematology Association / EHA 2002;3(5):259-63.
2001: Eva Lengfelder; Rüdiger Hehlmann; T Büchner
[Current therapeutic concept of acute promyelocytic leukemia].
Deutsche medizinische Wochenschrift (1946) 2001;126(39):1073-9.
2000: S Klugbauer; A Jauch; Eva Lengfelder; EP Demidchik; Hartmut M Rabes
A novel type of RET rearrangement (PTC8) in childhood papillary thyroid carcinomas and characterization of the involved gene (RFG8).
Cancer research 2000;60(24):7028-32.
2000: Eva Lengfelder; Rüdiger Hehlmann
[Polycythemia vera: current status of therapy].
Deutsche medizinische Wochenschrift (1946) 2000;125(41):1243-7.
2000: Eva Lengfelder; Anja Reichert; Claudia Schoch; Detlef Haase; Torsten Haferlach; Helmut Löffler; Peter Staib; Axel Heyll; Wolfgang Seifarth; Susanne Saussele; Christa Fonatsch; Winfried Gassmann; Wolf-Dieter Ludwig; Andreas Hochhaus; D Beelen; Carlo Aul; Maria Cristina Sauerland; Achim Heinecke; Rüdiger Hehlmann; Bernhard Wörmann; Wolfgang Hiddemann; Thomas Büchner
Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia. German AML Cooperative Group.
Leukemia 2000;14(8):1362-70.
2000: K Salassidis; J Bruch; Horst Zitzelsberger; Eva Lengfelder; Albrecht M Kellerer; M Bauchinger
Translocation t(10;14)(q11.2:q22.1) fusing the kinetin to the RET gene creates a novel rearranged form (PTC8) of the RET proto-oncogene in radiation-induced childhood papillary thyroid carcinoma.
Cancer research 2000;60(11):2786-9.
2000: Eva Lengfelder; Ute Berger; Rüdiger Hehlmann
Interferon alpha in the treatment of polycythemia vera.
Annals of hematology 2000;79(3):103-9.
2000: Hartmut M Rabes; EP Demidchik; J D Sidorow; Eva Lengfelder; C Beimfohr; D Hoelzel; S Klugbauer
Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-chernobyl papillary thyroid carcinomas: biological, phenotypic, and clinical implications.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(3):1093-103.
1999: H E Richter; HD Lohrer; Ludwig Hieber; Albrecht M Kellerer; Eva Lengfelder; M Bauchinger
Microsatellite instability and loss of heterozygosity in radiation-associated thyroid carcinomas of Belarussian children and adults.
Carcinogenesis 1999;20(12):2247-52.
1999: Thomas Büchner; Wolfgang Hiddemann; Bernhard Wörmann; Helmut Löffler; Winfried Gassmann; Torsten Haferlach; Christa Fonatsch; Detlef Haase; Claudia Schoch; Dieter K Hossfeld; Eva Lengfelder; Carlo Aul; Axel Heyll; Georg Maschmeyer; Wolf-Dieter Ludwig; Maria Cristina Sauerland; Achim Heinecke
Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative Group.
Blood 1999;93(12):4116-24.
1999: C Beimfohr; S Klugbauer; EP Demidchik; Eva Lengfelder; Hartmut M Rabes
NTRK1 re-arrangement in papillary thyroid carcinomas of children after the Chernobyl reactor accident.
International journal of cancer. Journal international du cancer 1999;80(6):842-7.
1999: JJ Michiels; Jack Kutti; P Stark; M Bazzan; Luigi Gugliotta; Roberto Marchioli; Martin Griesshammer; Perry van Genderen; Josette Brière; Jean-Jacques Kiladjian; Tiziano Barbui; Guido Finazzi; N I Berlin; T C Pearson; A C Green; S M Fruchtmann; Richard T Silver; E Hansmann; A Wehmeier; Eva Lengfelder; Raffaele Landolfi; Hans Michael Kvasnicka; Hans Carl Hasselbalch; Francisco Cervantes; J Thiele
Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis.
The Netherlands journal of medicine 1999;54(2):46-62.
1999: Jan Smida; K Salassidis; Ludwig Hieber; Horst Zitzelsberger; Albrecht M Kellerer; EP Demidchik; T Negele; Fritz Spelsberg; Eva Lengfelder; Martin Werner; M Bauchinger
Distinct frequency of ret rearrangements in papillary thyroid carcinomas of children and adults from Belarus.
International journal of cancer. Journal international du cancer 1999;80(1):32-8.
1999: Horst Zitzelsberger; L Lehmann; Ludwig Hieber; H U Weier; C Janish; J Fung; T Negele; Fritz Spelsberg; Eva Lengfelder; EP Demidchik; K Salassidis; Albrecht M Kellerer; Martin Werner; M Bauchinger
Cytogenetic changes in radiation-induced tumors of the thyroid.
Cancer research 1999;59(1):135-40.
1998: Berthold Streubel; Cristina Sauerland; Gerhard Heil; M Freund; H Bartels; Eva Lengfelder; Hannes Wandt; W D Ludwig; H Nowotny; M Baldus; B Grothaus-Pinke; Thomas Büchner; Christa Fonatsch
Correlation of cytogenetic, molecular cytogenetic, and clinical findings in 59 patients with ANLL or MDS and abnormalities of the short arm of chromosome 12.
British journal of haematology 1998;100(3):521-33.
1998: S Klugbauer; EP Demidchik; Eva Lengfelder; Hartmut M Rabes
Molecular analysis of new subtypes of ELE/RET rearrangements, their reciprocal transcripts and breakpoints in papillary thyroid carcinomas of children after Chernobyl.
Oncogene 1998;16(5):671-5.
1998: S Klugbauer; EP Demidchik; Eva Lengfelder; Hartmut M Rabes
Detection of a novel type of RET rearrangement (PTC5) in thyroid carcinomas after Chernobyl and analysis of the involved RET-fused gene RFG5.
Cancer research 1998;58(2):198-203.
1998: Eva Lengfelder; Andreas Hochhaus; U Kronawitter; D Höche; Wolfgang Queisser; M Jahn-Eder; R Burkhardt; Andreas Reiter; H Ansari; Rüdiger Hehlmann
Should a platelet limit of 600 x 10(9)/l be used as a diagnostic criterion in essential thrombocythaemia? An analysis of the natural course including early stages.
British journal of haematology 1998;100(1):15-23.
1997: Jan Smida; Horst Zitzelsberger; Albrecht M Kellerer; L Lehmann; G Minkus; T Negele; Fritz Spelsberg; Ludwig Hieber; EP Demidchik; Eva Lengfelder; M Bauchinger
p53 mutations in childhood thyroid tumours from Belarus and in thyroid tumours without radiation history.
International journal of cancer. Journal international du cancer 1997;73(6):802-7.
1997: Rüdiger Hehlmann; Andreas Willer; Hermann Heimpel; Joerg Hasford; Hans-Jochem Kolb; Hans Pralle; Dieter K Hossfeld; Wolfgang Queisser; Helmut Löffler; Andreas Hochhaus; Andreas Tobler; Eva Lengfelder; Ute Berger; Christine Leib-Mösch
Randomized studies with interferon in chronic myelogenous leukemia (CML) and comparative molecular aspects. German CML Study Group.
Leukemia 1997;11 Suppl 3():506-11.
1996: L Lehmann; Horst Zitzelsberger; Albrecht M Kellerer; Herbert Braselmann; U Kulka; V Georgiadou-Schumacher; T Negele; Fritz Spelsberg; EP Demidchik; Eva Lengfelder; M Bauchinger
Chromosome translocations in thyroid tissues from Belarussian children exposed to radioiodine from the Chernobyl accident, measured by FISH-painting.
International journal of radiation biology 1996;70(5):513-6.
1996: S Klugbauer; Eva Lengfelder; EP Demidchik; Hartmut M Rabes
A new form of RET rearrangement in thyroid carcinomas of children after the Chernobyl reactor accident.
Oncogene 1996;13(5):1099-1102.
1996: Claudia Schoch; Detlef Haase; Torsten Haferlach; Mathias Freund; H Link; Eva Lengfelder; Helmut Löffler; Thomas Büchner; Christa Fonatsch
Incidence and implication of additional chromosome aberrations in acute promyelocytic leukaemia with translocation t(15;17)(q22;q21): a report on 50 patients.
British journal of haematology 1996;94(3):493-500.
1996: Claudia Schoch; Detlef Haase; Torsten Haferlach; H Gudat; Thomas Büchner; Mathias Freund; H Link; Eva Lengfelder; Hannes Wandt; Maria Cristina Sauerland; Helmut Löffler; Christa Fonatsch
Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22;q22): an additional deletion in 9q is an adverse prognostic factor.
Leukemia 1996;10(8):1288-95.
1995: S Klugbauer; Eva Lengfelder; EP Demidchik; Hartmut M Rabes
High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident.
Oncogene 1995;11(12):2459-67.
1995: Eva Lengfelder; R Hehlmann
[Treatment of myelodysplastic syndromes aside from clinical studies].
Deutsche medizinische Wochenschrift (1946) 1995;120(44):1527.
1994: Eva Lengfelder; M Simon; Detlef Haase; F Hild; R Hehlmann
[Complete remission in acute promyelocytic leukemia. The advantages of all-trans-retinoic acid compared to conventional chemotherapy].
Deutsche medizinische Wochenschrift (1946) 1994;119(34-35):1143-50.
1994: Christa Fonatsch; H Gudat; Eva Lengfelder; Hannes Wandt; G Silling-Engelhardt; Wolf-Dieter Ludwig; E Thiel; Mathias Freund; H Bodenstein; G Schwieder
Correlation of cytogenetic findings with clinical features in 18 patients with inv(3)(q21q26) or t(3;3)(q21;q26).
Leukemia 1994;8(8):1318-26.